New CEO Readies Silicon Genetics for Scale-up (And a Little Bit More Recognition) in 2003 | GenomeWeb

Silicon Genetics CEO Saeid Akhtari is faced with what he describes as “a great problem” when it comes to brand recognition of the company’s flagship product, GeneSpring. “I’ve been introduced as the CEO of GeneSpring; we get checks made out to GeneSpring,” he said, without the slightest concern that more people know the name of the gene expression analysis software than that of the company who developed it. “Microsoft,” he pointed out, “was once known as the ‘DOS company.’”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.